Business Context and Reporting Period
Company: Novo Nordisk A/S
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: February 4, 2026
Context: Announcement of the initiation of the 2026 share repurchase programme.
Key Financial Metrics
This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial data relates to capital allocation:
- Total 2026 Repurchase Programme: Up to DKK 15 billion.
- Initial Tranche Amount: Up to DKK 3.8 billion.
- Maximum Shares Eligible: 400,000,000 B shares (DKK 0.10 nominal value).
- Execution Period (Initial Tranche): February 4, 2026, through May 4, 2026.
Material Changes
The filing announces the commencement of a new share repurchase initiative. This action is authorized by the Annual General Meeting held on March 27, 2025. The programme aims to reduce share capital and fulfill obligations related to share-based incentive programmes.
Guidance, Outlook, and Risks
- Management Commentary: The programme is designed to return capital to shareholders and manage share-based compensation liabilities.
- Regulatory Compliance: The programme will be conducted in accordance with Article 5 of Regulation No 596/2014 (MAR) and the "Safe Harbour Rules" (Commission Delegated Regulation (EU) 2016/1052).
- Contingencies: Continuation of the share repurchase programme beyond March 26, 2026, is conditional upon receiving new authorization at the 2026 Annual General Meeting.
- Lead Manager: Nordea Danmark, Filial af Nordea Bank Abp, Finland.
Investor Verification Checklist
- Verify the total remaining authorization under the DKK 15 billion 2026 programme after the initial DKK 3.8 billion tranche.
- Confirm the outcome of the 2026 Annual General Meeting regarding the extension of repurchase authority beyond March 26, 2026.
- Monitor actual execution volumes against the maximum 400,000,000 B share limit for the initial trading period.
- Review subsequent filings for updates on the impact of repurchases on total share capital and earnings per share.